SMT201500015B - Composizione farmaceutica comprendente (1S)-1,5-anidro-1-[5-(4-etossibenzil)-2- metossi-4-metilfenil]-1-tio-d-glucitolo e un secretagogo dell'insulina - Google Patents

Composizione farmaceutica comprendente (1S)-1,5-anidro-1-[5-(4-etossibenzil)-2- metossi-4-metilfenil]-1-tio-d-glucitolo e un secretagogo dell'insulina

Info

Publication number: SMT201500015B
Authority: SM; San Marino
Prior art keywords: ethoxybenzyl; glucitol; anhydro; thio; methylphenyl
Prior art date: 2009-04-16

Application number

SM201500015T

Other languages

English (en)

Inventor

Teisuke Takahashi

Saeko Uchida

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-16

Filing date

2015-01-19

Publication date

2015-03-05

2015-01-19 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

2015-03-05 Publication of SMT201500015B publication Critical patent/SMT201500015B/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SM201500015T 2009-04-16 2015-01-19 Composizione farmaceutica comprendente (1S)-1,5-anidro-1-[5-(4-etossibenzil)-2- metossi-4-metilfenil]-1-tio-d-glucitolo e un secretagogo dell'insulina SMT201500015B (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2009100210		2009-04-16
PCT/JP2010/057196 WO2010119990A1 (en)	2009-04-16	2010-04-16	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
SMT201500015B true SMT201500015B (it)	2015-03-05

Family

ID=42982643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201500015T SMT201500015B (it)	2009-04-16	2015-01-19	Composizione farmaceutica comprendente (1S)-1,5-anidro-1-[5-(4-etossibenzil)-2- metossi-4-metilfenil]-1-tio-d-glucitolo e un secretagogo dell'insulina

Country Status (30)

Country	Link
US (1)	US20120040898A1 (it)
EP (3)	EP2419097B1 (it)
JP (4)	JP5077786B2 (it)
KR (2)	KR20150046382A (it)
CN (7)	CN105343880A (it)
AR (1)	AR076317A1 (it)
AU (1)	AU2010237748B2 (it)
BR (1)	BRPI1012539A2 (it)
CA (1)	CA2755392A1 (it)
CY (2)	CY1114703T1 (it)
DK (2)	DK2419097T3 (it)
ES (2)	ES2431300T3 (it)
HK (6)	HK1217301A1 (it)
HR (2)	HRP20131120T1 (it)
ME (2)	ME02015B (it)
MX (1)	MX2011010901A (it)
MY (3)	MY183793A (it)
NZ (4)	NZ606888A (it)
PH (3)	PH12015500235B1 (it)
PL (2)	PL2419097T3 (it)
PT (2)	PT2419097E (it)
RS (2)	RS53056B (it)
RU (2)	RU2532330C2 (it)
SG (6)	SG2014012553A (it)
SI (2)	SI2601949T1 (it)
SM (1)	SMT201500015B (it)
TW (3)	TW201622720A (it)
UA (2)	UA111742C2 (it)
WO (1)	WO2010119990A1 (it)
ZA (1)	ZA201106727B (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7772191B2 (en)	2005-05-10	2010-08-10	Boehringer Ingelheim International Gmbh	Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
DK2486029T3 (en)	2009-09-30	2015-08-24	Boehringer Ingelheim Int	Methods of making of glucopyranosyl-substituted benzyl-benzene derivatives.
UY32919A (es)	2009-10-02	2011-04-29	Boehringer Ingelheim Int	Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
US20120283169A1 (en) *	2010-11-08	2012-11-08	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
TR201101809A1 (tr) *	2010-12-21	2012-07-23	Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇	Vildagliptin ve glimepirid kombinasyonları.
US9192617B2 (en)	2012-03-20	2015-11-24	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
KR20150013838A (ko)	2012-05-17	2015-02-05	트랜스테크 파르마 엘엘씨	당뇨병 치료를 위한 글루코키나아제 활성화제 조성물
BR112015004012A2 (pt)	2012-08-30	2017-07-04	Taisho Pharmaceutical Co Ltd	combinações de inibidores de sglt 2 e fármacos anti-hipertensivos
ES2702174T3 (es)	2013-04-05	2019-02-27	Boehringer Ingelheim Int	Usos terapéuticos de empagliflozina
US11813275B2 (en)	2013-04-05	2023-11-14	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
US20140303097A1 (en)	2013-04-05	2014-10-09	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
MX381599B (es)	2013-04-18	2025-03-12	Boehringer Ingelheim Int Gmbh	Empagliflozina para usarse en el tratamiento de micro y macroalbuminuria
TW201636015A (zh) *	2013-07-05	2016-10-16	卡地拉保健有限公司	協同性組成物
BR112017018329A2 (pt) *	2015-02-27	2018-08-07	The Asan Foundation	composição para prevenir ou tratar calcificação de válvula, contendo inibidor de dpp-4
CN105963280B (zh) *	2016-06-30	2018-11-06	合肥华方医药科技有限公司	一种伏格列波糖口腔速溶膜及其制备方法
MX2019004549A (es)	2016-10-19	2019-06-12	Boehringer Ingelheim Int	Combinaciones que comprenden un inhibidor ssao/vap-1 y un inhibidor sglt2 y usos de los mismos.
CN110168098A (zh) *	2016-11-14	2019-08-23	高雄医学大学	一种检测糖代谢异常的方法及其预防及治疗
AU2019254371A1 (en)	2018-04-17	2020-10-08	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
KR20190137343A (ko)	2018-06-01	2019-12-11	김유찬	계량 인덕션
JP2021526130A (ja)	2018-06-12	2021-09-30	ブイティーブイ・セラピューティクス・エルエルシー	インスリンまたはインスリン類似体と組み合わせたグルコキナーゼ活性化薬の治療的使用
JP7425793B2 (ja)	2018-10-29	2024-01-31	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ピリジニルスルホンアミド誘導体、医薬組成物およびそれらの使用
CA3112510A1 (en)	2018-10-29	2020-05-07	Boehringer Ingelheim International Gmbh	Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4432757A1 (de)	1994-09-14	1996-03-21	Boehringer Mannheim Gmbh	Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
JP2003520759A (ja)	1999-08-31	2003-07-08	アンドルックスファーマスーティカルズインコーポレーテッド	単位核を有する徐放性錠剤
CA2442917C (en) *	2001-04-04	2011-02-01	Ortho-Mcneil Pharmaceutical, Inc.	Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
ATE318272T1 (de) *	2001-04-11	2006-03-15	Bristol Myers Squibb Co	Aminosäurekomplexe von c-arylglycosiden zur behandlung von diabetes und verfahren
TW200637839A (en) *	2005-01-07	2006-11-01	Taisho Pharmaceutical Co Ltd	1-thio-d-glucitol derivatives
NZ573843A (en) *	2006-06-29	2011-02-25	Taisho Pharmaceutical Co Ltd	C-phenyl 1-thioglucitol compound
JP5194588B2 (ja) *	2006-07-06	2013-05-08	大正製薬株式会社	１−チオ−ｄ−グルシトール誘導体を有効成分として含有する糖尿病の予防又は治療剤
EP2054426A1 (en) *	2006-08-15	2009-05-06	Boehringer Ingelheim International GmbH	Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
CN101534815A (zh) *	2006-11-09	2009-09-16	贝林格尔.英格海姆国际有限公司	使用sglt-2抑制剂的组合治疗及其药物组合物
WO2008072726A1 (ja) *	2006-12-14	2008-06-19	Taisho Pharmaceutical Co., Ltd.	１－フェニル１－チオ－ｄ－グルシト－ル誘導体
PE20090603A1 (es)	2007-08-16	2009-06-11	Boehringer Ingelheim Int	Composicion farmaceutica que comprende un inhibidor de sglt2 y un inhibidor de dpp iv
CL2008002427A1 (es)	2007-08-16	2009-09-11	Boehringer Ingelheim Int	Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.

2010
- 2010-04-16 CN CN201510876739.3A patent/CN105343880A/zh active Pending
- 2010-04-16 BR BRPI1012539A patent/BRPI1012539A2/pt not_active IP Right Cessation
- 2010-04-16 RS RS20130508A patent/RS53056B/en unknown
- 2010-04-16 NZ NZ606888A patent/NZ606888A/en not_active IP Right Cessation
- 2010-04-16 EP EP10764570.7A patent/EP2419097B1/en active Active
- 2010-04-16 CN CN2010800169522A patent/CN102395364A/zh active Pending
- 2010-04-16 AU AU2010237748A patent/AU2010237748B2/en not_active Ceased
- 2010-04-16 SG SG2014012553A patent/SG2014012553A/en unknown
- 2010-04-16 SG SG2014014807A patent/SG2014014807A/en unknown
- 2010-04-16 WO PCT/JP2010/057196 patent/WO2010119990A1/en active Application Filing
- 2010-04-16 UA UAA201314870A patent/UA111742C2/uk unknown
- 2010-04-16 SG SG2014012405A patent/SG2014012405A/en unknown
- 2010-04-16 EP EP13157571.4A patent/EP2601949B1/en active Active
- 2010-04-16 PT PT107645707T patent/PT2419097E/pt unknown
- 2010-04-16 AR ARP100101273A patent/AR076317A1/es unknown
- 2010-04-16 RS RS20150042A patent/RS53761B1/en unknown
- 2010-04-16 TW TW105105937A patent/TW201622720A/zh unknown
- 2010-04-16 RU RU2011146335/15A patent/RU2532330C2/ru not_active IP Right Cessation
- 2010-04-16 US US13/264,687 patent/US20120040898A1/en not_active Abandoned
- 2010-04-16 MX MX2011010901A patent/MX2011010901A/es active IP Right Grant
- 2010-04-16 JP JP2011540651A patent/JP5077786B2/ja active Active
- 2010-04-16 PT PT131575714T patent/PT2601949E/pt unknown
- 2010-04-16 CN CN201510876678.0A patent/CN105477639A/zh active Pending
- 2010-04-16 CN CN201510876712.4A patent/CN105343871A/zh active Pending
- 2010-04-16 SI SI201030784T patent/SI2601949T1/sl unknown
- 2010-04-16 ME MEP-2015-6A patent/ME02015B/me unknown
- 2010-04-16 NZ NZ595314A patent/NZ595314A/xx unknown
- 2010-04-16 CA CA2755392A patent/CA2755392A1/en not_active Abandoned
- 2010-04-16 PL PL10764570T patent/PL2419097T3/pl unknown
- 2010-04-16 TW TW099111992A patent/TW201103534A/zh unknown
- 2010-04-16 EP EP14183168.5A patent/EP2829271A3/en not_active Withdrawn
- 2010-04-16 CN CN201510876753.3A patent/CN105434430A/zh active Pending
- 2010-04-16 TW TW103133246A patent/TW201500043A/zh unknown
- 2010-04-16 SG SG2014012462A patent/SG2014012462A/en unknown
- 2010-04-16 ES ES10764570T patent/ES2431300T3/es active Active
- 2010-04-16 UA UAA201113444A patent/UA105216C2/ru unknown
- 2010-04-16 MY MYPI2015001281A patent/MY183793A/en unknown
- 2010-04-16 KR KR1020157009538A patent/KR20150046382A/ko not_active Ceased
- 2010-04-16 SG SG2014015093A patent/SG2014015093A/en unknown
- 2010-04-16 SG SG2011073848A patent/SG175154A1/en unknown
- 2010-04-16 MY MYPI2011004937A patent/MY156679A/en unknown
- 2010-04-16 CN CN201510876708.8A patent/CN105343060A/zh active Pending
- 2010-04-16 ME MEP-2013-137A patent/ME01555B/me unknown
- 2010-04-16 NZ NZ710575A patent/NZ710575A/en not_active IP Right Cessation
- 2010-04-16 NZ NZ623838A patent/NZ623838A/en not_active IP Right Cessation
- 2010-04-16 PL PL13157571T patent/PL2601949T3/pl unknown
- 2010-04-16 ES ES13157571.4T patent/ES2523408T3/es active Active
- 2010-04-16 MY MYPI2015001283A patent/MY182720A/en unknown
- 2010-04-16 DK DK10764570.7T patent/DK2419097T3/da active
- 2010-04-16 DK DK13157571.4T patent/DK2601949T3/da active
- 2010-04-16 SI SI201030365T patent/SI2419097T1/sl unknown
- 2010-04-16 KR KR1020117023612A patent/KR20120016051A/ko not_active Ceased
- 2010-04-16 CN CN201510876636.7A patent/CN105343059A/zh active Pending
2011
- 2011-09-14 ZA ZA2011/06727A patent/ZA201106727B/en unknown
2012
- 2012-08-31 JP JP2012191753A patent/JP5660094B2/ja not_active Expired - Fee Related
2013
- 2013-11-25 HR HRP20131120AT patent/HRP20131120T1/hr unknown
- 2013-12-05 CY CY20131101103T patent/CY1114703T1/el unknown
2014
- 2014-05-26 RU RU2014121260/15A patent/RU2014121260A/ru not_active Application Discontinuation
- 2014-11-05 HR HRP20141080AT patent/HRP20141080T1/hr unknown
- 2014-12-03 JP JP2014245257A patent/JP5910711B2/ja active Active
2015
- 2015-01-16 CY CY20151100045T patent/CY1115907T1/el unknown
- 2015-01-19 SM SM201500015T patent/SMT201500015B/it unknown
- 2015-02-03 PH PH12015500235A patent/PH12015500235B1/en unknown
- 2015-12-25 JP JP2015253932A patent/JP6066144B2/ja active Active
2016
- 2016-05-11 HK HK16105348.0A patent/HK1217301A1/zh unknown
- 2016-05-11 HK HK16105353.2A patent/HK1217302A1/zh unknown
- 2016-05-12 HK HK16105417.6A patent/HK1217435A1/zh unknown
- 2016-05-12 HK HK16105415.8A patent/HK1217434A1/zh unknown
- 2016-06-16 HK HK16106920.4A patent/HK1218871A1/zh unknown
- 2016-06-17 HK HK16106970.3A patent/HK1218881A1/zh unknown
2019
- 2019-04-30 PH PH12019500961A patent/PH12019500961B1/en unknown
- 2019-04-30 PH PH12019500959A patent/PH12019500959B1/en unknown

Also Published As

Publication number	Publication date
KR20120016051A (ko)	2012-02-22
CY1115907T1 (el)	2017-01-25
SI2419097T1 (sl)	2014-01-31
SG2014012462A (en)	2014-05-29
MY156679A (en)	2016-03-15
HK1218881A1 (zh)	2017-03-17
JP5910711B2 (ja)	2016-04-27
AU2010237748B2 (en)	2014-10-30
HK1218871A1 (zh)	2017-03-17
CN105477639A (zh)	2016-04-13
JP5660094B2 (ja)	2015-01-28
ZA201106727B (en)	2012-11-28
NZ710575A (en)	2016-06-24
PH12019500959A1 (en)	2020-06-29
SG2014015093A (en)	2014-04-28
JP2012524710A (ja)	2012-10-18
SG2014012553A (en)	2014-05-29
HK1217301A1 (zh)	2017-01-06
ME01555B (me)	2014-04-20
HK1217302A1 (zh)	2017-01-06
EP2829271A3 (en)	2015-05-27
CY1114703T1 (el)	2016-10-05
CN102395364A (zh)	2012-03-28
JP5077786B2 (ja)	2012-11-21
DK2601949T3 (da)	2015-01-05
PH12015500235A1 (en)	2015-12-02
EP2601949A2 (en)	2013-06-12
NZ606888A (en)	2014-07-25
PH12019500961A1 (en)	2020-08-03
CN105343871A (zh)	2016-02-24
AR076317A1 (es)	2011-06-01
RS53056B (en)	2014-04-30
RU2014121260A (ru)	2015-12-10
JP2013006854A (ja)	2013-01-10
US20120040898A1 (en)	2012-02-16
EP2829271A2 (en)	2015-01-28
HRP20141080T1 (hr)	2015-01-02
DK2419097T3 (da)	2013-10-28
KR20150046382A (ko)	2015-04-29
PH12019500961B1 (en)	2020-08-03
RU2011146335A (ru)	2013-05-27
PL2419097T3 (pl)	2014-02-28
BRPI1012539A2 (pt)	2016-03-29
MY183793A (en)	2021-03-16
HK1217434A1 (zh)	2017-01-13
SG175154A1 (en)	2011-11-28
TW201103534A (en)	2011-02-01
PL2601949T3 (pl)	2015-04-30
RU2532330C2 (ru)	2014-11-10
SG2014014807A (en)	2014-05-29
JP2015063543A (ja)	2015-04-09
HRP20131120T1 (hr)	2013-12-20
JP2016104775A (ja)	2016-06-09
TW201500043A (zh)	2015-01-01
PT2419097E (pt)	2013-10-03
MX2011010901A (es)	2011-11-01
PH12019500959B1 (en)	2020-06-29
NZ623838A (en)	2015-09-25
EP2419097A1 (en)	2012-02-22
CN105343059A (zh)	2016-02-24
EP2419097A4 (en)	2012-09-05
JP6066144B2 (ja)	2017-01-25
MY182720A (en)	2021-02-03
UA105216C2 (en)	2014-04-25
PT2601949E (pt)	2014-11-12
TW201622720A (zh)	2016-07-01
WO2010119990A1 (en)	2010-10-21
PH12015500235B1 (en)	2015-12-02
AU2010237748A1 (en)	2011-10-20
ES2523408T3 (es)	2014-11-25
ME02015B (me)	2015-05-20
HK1217435A1 (zh)	2017-01-13
ES2431300T3 (es)	2013-11-25
EP2601949A3 (en)	2013-09-18
SI2601949T1 (sl)	2014-12-31
SG2014012405A (en)	2014-05-29
CN105434430A (zh)	2016-03-30
EP2601949B1 (en)	2014-10-29
EP2419097B1 (en)	2013-09-25
CA2755392A1 (en)	2010-10-21
NZ595314A (en)	2013-03-28
CN105343880A (zh)	2016-02-24
CN105343060A (zh)	2016-02-24
RS53761B1 (en)	2015-06-30
UA111742C2 (uk)	2016-06-10

Publication	Publication Date	Title
SMT201500015B (it)	2015-03-05	Composizione farmaceutica comprendente (1S)-1,5-anidro-1-[5-(4-etossibenzil)-2- metossi-4-metilfenil]-1-tio-d-glucitolo e un secretagogo dell'insulina
CY2017023I1 (el)	2017-11-14	Φαρμακευτικη συνθεση που περιλαμβανει εναν glp-1-αγωνιστη, μια ινσουλινη, και μεθειονινη
BRPI1010772A2 (pt)	2016-11-01	composto,e, composição farmacêutica.
BRPI0820535A2 (pt)	2016-06-21	composições farmacêuticas contendo insulina e um peptídeo insulinotrópico
HUE042286T2 (hu)	2019-06-28	Tûvel szerelt, elõre töltött belövõ fecskendõ
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BRPI1014760A2 (pt)	2017-07-18	preparacao compreendendo insulina, nicotinamida e um aminoacido
IL211400A0 (en)	2011-05-31	Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
BRPI0909084A2 (pt)	2015-08-11	Composição líquida, e, composto de peptídeo.
IL206789A (en)	2015-11-30	A converted cyclic amide compound, a pharmaceutical preparation containing the compound and the use of a compound or pharmaceutical preparation in a pharmaceutical preparation
DE602007014294D1 (de)	2011-06-16	Kapselbehälter
IL199397A (en)	2014-07-31	Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
BRPI1007018A2 (pt)	2016-03-29	composto, composição farmacêutica, e , uso de um composto.
DK2029458T3 (da)	2011-05-02	Kapsel med mindsket dryppen
BR112012004335A2 (pt)	2015-09-08	composto, composição farmacêutica, e, uso do composto.
BR112012003800A2 (pt)	2016-11-22	composição, peptídeo, e formulação farmacêutica.
BRPI1008906A2 (pt)	2016-03-15	composto, composição farmacêutica, e, uso de um composto.
BRPI0812354A2 (pt)	2015-01-27	Composição farmacêutica não-aquosa.
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
BRPI1014583A2 (pt)	2016-04-26	sulfonamidas heterocíclicos, composições farmacêuticas e usos do mesmo.
BRPI1009823A2 (pt)	2019-09-24	"composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
BRPI1009757A2 (pt)	2016-03-15	composto, composição farmacêutica, e , uso de um composto.
BRPI0911772A2 (pt)	2017-06-27	composto, composição farmacêutica, e, uso do composto.
BRPI0914182A2 (pt)	2019-09-24	composto, e, composição farmacêutica